Infertility Treatment Devices Industry is projected to witness a CAGR of 8.4% during the period 2023-2032. This growth can be attributed to the increasing.
Revenue up 16% to $15.7 million and Adjusted EBITDA up 3% to $2.2 million for the quarterBEVERLY, Mass. and TORONTO, Nov. 13, 2023 Hamilton Thorne Ltd. , a leading provider of precision.
BEVERLY, Mass. and TORONTO, Nov. 07, 2023 Hamilton Thorne Ltd. , a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ,.
BEVERLY, Mass. and TORONTO, Nov. 07, 2023 (GLOBE NEWSWIRE) Hamilton Thorne Ltd. (TSX:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies